An email has been sent to your address with instructions for changing your password.
There is no user registered with this email.
Sign Up
To create a free account, please fill out the form below.
Thank you for signing up!
A confirmation email has been sent to your email address. Please check your email and follow the instructions in the message to complete the registration process. If you do not receive the email, please check your spam folder or contact us for assistance.
Welcome to our platform!
Oops!
Something went wrong while trying to create your new account. Please try again and if the problem persist, Email Us to receive support.
Karuna Therapeutics to Present at Upcoming Investor Conferences
Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Karuna Therapeutics (NASDAQ: KRTX) has announced that its senior management will present at several investor conferences in September 2022. Key events include Citi’s 17th Annual BioPharma Conference on September 7 at 9:40 a.m. ET, Wells Fargo Healthcare Conference on September 8 at 9:45 a.m. ET, and Morgan Stanley’s 20th Annual Global Healthcare Conference on September 12 at 8:10 a.m. ET. Live webcasts will be accessible on Karuna's Investor Relations page, with archived replays available for 30 days.
Positive
None.
Negative
None.
BOSTON--(BUSINESS WIRE)--
Karuna Therapeutics, Inc. (NASDAQ: KRTX), a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions, today announced that senior management will present at the following upcoming investor conferences:
Citi’s 17th Annual BioPharma Conference Date: Wednesday, September 7, 2022 Time: 9:40 a.m. ET
2022 Wells Fargo Healthcare Conference Date: Thursday, September 8, 2022 Time: 9:45 a.m. ET
Morgan Stanley 20th Annual Global Healthcare Conference
Date: Monday, September 12, 2022 Time: 8:10 a.m. ET
A live webcast of the presentations will be available on the Investor Relations page of Karuna’s website at investors.karunatx.com. A replay of the webcasts will also be archived for up to 30 days on Karuna’s website following the conference.
About Karuna Therapeutics Karuna Therapeutics is a clinical-stage biopharmaceutical company driven to create and deliver transformative medicines for people living with psychiatric and neurological conditions. At Karuna, we understand there is a need for differentiated and more effective treatments that can help patients navigate the challenges presented by serious mental illness. Utilizing our extensive knowledge of neuroscience, we are harnessing the untapped potential of the brain in pursuit of novel pathways to develop medicines that make meaningful differences in peoples’ lives. For more information, please visit www.karunatx.com.